1. Considerations for the conduct of clinical trials of medical products during major disruptions due to disasters and public health emergencies: guidance for industry, investigators, and institutional review boards Publication: Silver Spring, MD : Center for Drug Evaluation and Research, September 2023 Subject(s): Clinical Trials as TopicDisastersEmergenciesGovernment RegulationPublic HealthUnited States
